Don’t you wonder if now is the time to start analysing the iShares S&P Global Healthcare ETF (ASX: IXJ) and Vanguard Global Infrastructure Index ETF (ASX: VBLD)? These Exchange-Traded Funds (ETFs) operate in the International shares sector, a key sector for diversified portfolios.
Is the IXJ ETF a good investment? Here’s where you start…
The iShares IXJ ETF provides investors with a targeted exposure to over 100 global healthcare companies. This includes companies in the pharmaceutical, biotechnology, and medical device space.
According to our most recent data, the IXJ ETF had $798.97 million of money invested. With IXJ’s total funds under management (FUM) figure over $100 million, the ETF meets our team’s minimum investment criteria for FUM levels. As a general rule, our team draws the line at $100 million for ETFs in the International shares sector because we believe that, relative to smaller ETFs, achieving this amount of FUM lowers the chance that the ETF issuer will close the ETF.
Get our team’s IXJ ETF review, available free when you click this link: access the free investment report.
A quick take of the VBLD ETF
The Vanguard VBLD ETF gives investors exposure to a range of infrastructure securities listed in developed markets around the world. This ETF also provides exposure to currency fluctuations as it is unhedged.
With our numbers for December 2020, VBLD’s FUM stood at $107.97 million. Since the VBLD’s FUM is over $100 million, our investing team would say the ETF has met our minimum criteria for the total amount invested, otherwise known as FUM. A very sustainable ETF in the Infrastructure sector should be able to scale well and become profitable for the ETF issuer.
Are the fees for the VBLD ETF bad?
Vanguard, the ETF issuer, charges a yearly management fee of 0.47% for the VBLD ETF. Meaning, if you invested $2,000 for a full 12-month period you could expect to pay a base management fee of around $9.40.
The management fee is above the average for all ETFs on our list of ASX ETFs, but keep in mind the ETF may be able to justify the higher price tag with superior performance over time.
Did you know: you can get our full ETF review of VBLD by clicking here?
[ls_content_block id=”4954″ para=”paragraphs”]
